Asa Abeliovich

Company: Leal Therapeutics

Job title: Chief Executive Officer & Founder

Seminars:

Panel Discussion: Uniting Forces: Collaborative Initiatives Driving ALS Drug Development Through Data Sharing & Accelerated Research 5:10 pm

How are these initiatives complementing each other in the ALS research space? What are the biggest hurdles in harmonizing and sharing data across these programs? How do we ensure that patient-centric approaches remain at the forefront of these efforts? What are the best practices for ensuring standardization and quality of collected data? How can international…Read more

day: Conference Day One PM

Workshop A: Pioneering Modalities for ALS: Unpacking the Gene Therapy Toolbox & Beyond 9:30 am

From gene editing and augmentation to emerging delivery systems and knockdown strategies, the session will provide a comprehensive exploration of the gene therapy landscape. Participants will discuss which technologies are best suited for targeting specific ALS mutations, the challenges of sporadic versus hereditary forms, and the broader application of current platforms. By analyzing both successes…Read more

day: Pre Conference Day Workshop Track A